Early-onset colorectal cancer (EO-CRC) incidence is rising worldwide, but it remains unclear whether EO-CRC is biologically distinct from standard-onset CRC (SO-CRC). We analyzed EO-CRC and SO-CRC using integrated proteomic, transcriptomic, genomic, histologic, and patient-derived organoid analyses. We identified enrichment of the placental-like developmental, extracellular matrix, and immunomodulatory programs in EO-CRC. EO-CRC tumors also showed increased expression of the human endogenous retrovirus subfamily H (HERVH) associated with placental-like protein expression and supported tumor growth and stem-like features. Antisense oligonucleotide-mediated HERVH depletion reduced organoid growth and LGR5 expression. EO-CRC displayed distinct nuclear morphometric features and altered extracellular matrix, consistent with a mechanically altered microenvironment associated with YAP signaling, a major placental development regulator. Consistent with mechanical and replication stress, HERVH-high-expressing EO-CRC organoids showed increased sensitivity to ataxia telangiectasia and Rad3-related (ATR) inhibition. These findings indicate that EO-CRC is characterized by placental-like reprogramming and HERVH activation, providing a potential explanation for its aggressive behavior and highlighting new opportunities for therapeutic strategies.
Placental-like reprogramming associated with HERV elements in early-onset colorectal cancer / Mauri, G., Santorelli, L., Marasca, F., Ranzani, V., Crisafulli, G., Bertolio, R., Vadalà, R., Bevilacqua, V., Kallio, P., Gasparotto, E., Puzzono, M., Baraibar, I., Tonani, M., Salviati, L., Sogari, A., Scardellato, S., Ghezzi, S., Mariano, S., Saoudi-González, N., Monti, L., et al.. - In: CELL PRESS BLUE. - ISSN 3051-3839. - (2026), pp. 1-17. [Epub ahead of print] [10.1016/j.cpblue.2026.100133]
Placental-like reprogramming associated with HERV elements in early-onset colorectal cancer
Bertolio, Rebecca;Napoletano, Francesco;Del Sal, Giannino;
2026-01-01
Abstract
Early-onset colorectal cancer (EO-CRC) incidence is rising worldwide, but it remains unclear whether EO-CRC is biologically distinct from standard-onset CRC (SO-CRC). We analyzed EO-CRC and SO-CRC using integrated proteomic, transcriptomic, genomic, histologic, and patient-derived organoid analyses. We identified enrichment of the placental-like developmental, extracellular matrix, and immunomodulatory programs in EO-CRC. EO-CRC tumors also showed increased expression of the human endogenous retrovirus subfamily H (HERVH) associated with placental-like protein expression and supported tumor growth and stem-like features. Antisense oligonucleotide-mediated HERVH depletion reduced organoid growth and LGR5 expression. EO-CRC displayed distinct nuclear morphometric features and altered extracellular matrix, consistent with a mechanically altered microenvironment associated with YAP signaling, a major placental development regulator. Consistent with mechanical and replication stress, HERVH-high-expressing EO-CRC organoids showed increased sensitivity to ataxia telangiectasia and Rad3-related (ATR) inhibition. These findings indicate that EO-CRC is characterized by placental-like reprogramming and HERVH activation, providing a potential explanation for its aggressive behavior and highlighting new opportunities for therapeutic strategies.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


